Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 52, 2017 - Issue 5
Submit an article Journal homepage
253
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine

Carlos UreyDepartment of Surgery, Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden;
,
Bodil AnderssonDepartment of Surgery, Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden;
,
Daniel AnsariDepartment of Surgery, Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden;
,
Agata SasorDepartment of Pathology, Skåne University Hospital, Lund University, Lund, Sweden;
,
Katarzyna Said-HilmerssonDepartment of Surgery, Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden;
,
Johan NilssonDepartment of Cardiothoracic Surgery, Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden
&
Roland AnderssonDepartment of Surgery, Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden; Correspondence[email protected]
 show all
Pages 595-600 | Received 29 Dec 2016, Accepted 30 Jan 2017, Published online: 15 Feb 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shailendra K. Gautam, Sushil Kumar, Andrew Cannon, Bradley Hall, Rakesh Bhatia, Mohd Wasim Nasser, Sidharth Mahapatra, Surinder K. Batra & Maneesh Jain. (2017) MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. Expert Opinion on Therapeutic Targets 21:7, pages 657-669.
Read now

Articles from other publishers (7)

Aaron M. Mohs, Katie M. Muilenburg & Evie G. Ehrhorn. (2024) Targeting mucins for fluorescence-guided surgery of pancreatic cancer. Targeting mucins for fluorescence-guided surgery of pancreatic cancer.
Yu Pu, Helin Ke, Changqiang Wu, Shaodan Xu, Yang Xiao, Lina Han, Guorong Lyu & Shilin Li. (2023) Superparamagnetic iron oxide nanoparticles target BxPC-3 cells and silence MUC4 for the treatment of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:9, pages 130383.
Crossref
Shunda Wang, Lei You, Menghua Dai & Yupei Zhao. (2020) Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy. Journal of Cellular and Molecular Medicine 24:18, pages 10279-10289.
Crossref
Shailendra K. Gautam, Sushil Kumar, Vi Dam, Dario Ghersi, Maneesh Jain & Surinder K. Batra. (2020) MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Seminars in Immunology 47, pages 101391.
Crossref
YongKiat Wee, Yining Liu, Salma Begum Bhyan, Jiachun Lu & Min Zhao. (2019) The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers. Gene 697, pages 57-66.
Crossref
Ivan.P. Gorlov, Olga Y. Gorlova & Christopher I. Amos. (2019) Untouchable genes in the human genome: Identifying ideal targets for cancer treatment. Cancer Genetics 231-232, pages 67-79.
Crossref
Elisa Grassi, Sandra Durante, Annalisa Astolfi, Giuseppe Tarantino, Valentina Indio, Eva Freier, Silvia Vecchiarelli, Claudio Ricci, Riccardo Casadei, Francesca Formica, Daria Filippini, Francesca Comito, Carla Serra, Donatella Santini, Antonietta D' Errico, Francesco Minni, Guido Biasco & Mariacristina Di Marco. (2018) Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. International Journal of Oncology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.